End-of-life care/Surrogate decision making | Journal of Ethics | American Medical Association

End-of-life care/Surrogate decision making

Health Law
Nov 2020

How Hospital Leaders and Risk Managers Can Nurture Ethics-Driven Lawyering
Norine A. McGrath, MD, Evan G. DeRenzo, PhD, John K. Kilcullen, MD, JD, MPH, and Jack Schwartz, JD
Hospital lawyers’ practices shape risk management operations, influence clinicians’ morale, and affect patient care.
AMA J Ethics. 2020;22(11):E933-939. doi: 10.1001/amajethics.2020.933.
AMA Code Says
Nov 2020

AMA Code of Medical Ethics’ Opinions Related to Risk Management Ethics
Scott J. Schweikart, JD, MBE and Deborah M. Eng, MS, MA
Ethical dimensions of risk management are illuminated in AMA Code content on discharge planning.
AMA J Ethics. 2020;22(11):E940-944. doi: 10.1001/amajethics.2020.940.
Case and Commentary
Oct 2019

How Should Decision Science Inform Scarce Blood Product Allocation?
Eric Kersjes, MD and Lauren B. Smith, MD
Decision aids could help clinicians know when to request ethics consultation or re-evaluate blood product usage in a specific patient care situation.
AMA J Ethics. 2019;21(10):E852-857. doi: 10.1001/amajethics.2019.852.
Case and Commentary
Jul 2019

Should Dialysis Be Stopped for an Unrepresented Patient With Metastatic Cancer?
Adira Hulkower, JD, MS, Sarah Garijo-Garde, and Lauren S. Flicker, JD, MBE
Legal inconsistencies and variation in end-of-life options generate disparities in care for unrepresented patients.
AMA J Ethics. 2019;21(7):E575-581. doi: 10.1001/amajethics.2019.575.